| Heather R Dooley, PA | |
|
1622 Westgate Cir, Brentwood, TN 37027-8019 | |
| (629) 255-2232 | |
| (629) 255-4182 |
| Full Name | Heather R Dooley |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 25 Years |
| Location | 1622 Westgate Cir, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972776599 | NPI | - | NPPES |
| 811 | Other | TN | PA LICENSE |
| 1508690 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 811 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heritage Medical Associates Pc | 4688651037 | 158 |
News Archive
Today Biogen Idec announced that U.S. and EU regulatory authorities have accepted the marketing applications for the review of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis.
Marin Catholic High School (MCHS) and CSG, the worldwide leader in environmentally-beneficial surface treatments, today announced the school is the Bay Area's first education facility to integrate the Surface Antimicrobial System (SAS). The most environmentally friendly and long-lasting treatment of its kind, SAS has transformed 10,000 square feet of high-touch surfaces in Marin's athletic facility into materials that continuously inhibit the growth of harmful bacteria, mold, and fungi for three years.
Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather R Dooley, PA 222 22nd Ave N, Nashville, TN 37203-1852 Ph: (629) 255-3486 | Heather R Dooley, PA 1622 Westgate Cir, Brentwood, TN 37027-8019 Ph: (629) 255-2232 |
News Archive
Today Biogen Idec announced that U.S. and EU regulatory authorities have accepted the marketing applications for the review of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis.
Marin Catholic High School (MCHS) and CSG, the worldwide leader in environmentally-beneficial surface treatments, today announced the school is the Bay Area's first education facility to integrate the Surface Antimicrobial System (SAS). The most environmentally friendly and long-lasting treatment of its kind, SAS has transformed 10,000 square feet of high-touch surfaces in Marin's athletic facility into materials that continuously inhibit the growth of harmful bacteria, mold, and fungi for three years.
Odessa Memorial Healthcare Center in Odessa, Wash. is the first Critical Access Hospital (CAH) to successfully attest to Stage 2 of the Meaningful Use electronic health record (EHR) incentive program using MEDITECH Information Technology, Inc. administered by Engage, a division of Inland Northwest Health Services (INHS).
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.
› Verified 6 days ago
Stuart Jones, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 317 Seven Springs Way, Ste 101, Brentwood, TN 37027 Phone: 615-370-9992 | |
Stacey Leigh Groves, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 317 Seven Springs Way Ste 101, Brentwood, TN 37027 Phone: 615-370-9992 Fax: 615-370-9665 | |
Mr. Brian Keith Lovely, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 210 Franklin Rd Ste 4-b, Brentwood, TN 37027 Phone: 615-964-6160 | |
Emily E Burdette, Physician Assistant Medicare: Medicare Enrolled Practice Location: 5511 Virginia Way Ste 300, Brentwood, TN 37027 Phone: 615-994-1000 Fax: 615-994-0100 | |
Mrs. Misty Dawn Ward, P.A Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1607 Westgate Cir, Brentwood, TN 37027 Phone: 615-376-8195 | |
Ari Hardin, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1195 Old Hickory Blvd Ste 102, Brentwood, TN 37027 Phone: 615-834-7777 Fax: 615-834-7888 | |
Audrey Ann Becker, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1649 Westgate Cir, #100, Brentwood, TN 37027 Phone: 615-843-7546 Fax: 615-777-3376 |